HCV-话题@MedSci

#HCV#

247篇内容 | 3939人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257623, encodeId=8040125e62367, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：他汀类药物可帮助HCV患者降低肝硬化和HCC风险, objectType=article, longId=64398, objectId=79bb643989a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79bb643989a, replyNumber=0, likeNumber=77, createdTime=2016-03-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79bb643989a, moduleTitle=Hepatology：他汀类药物可帮助HCV患者降低肝硬化和HCC风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79bb643989a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257622, encodeId=5284125e62220, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Lancet infect dis：HIV合并HCV感染的负担（全球性meta分析）, objectType=article, longId=63900, objectId=c4cd63900c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4cd63900c5, replyNumber=0, likeNumber=117, createdTime=2016-02-29, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4cd63900c5, moduleTitle=Lancet infect dis：HIV合并HCV感染的负担（全球性meta分析）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4cd63900c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257621, encodeId=e195125e621ca, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：感染HCV对心血管疾病风险的影响, objectType=article, longId=62673, objectId=ff23626e3bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff23626e3bd, replyNumber=0, likeNumber=54, createdTime=2016-01-28, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff23626e3bd, moduleTitle=Gastroenterology：感染HCV对心血管疾病风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff23626e3bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257620, encodeId=8e7c125e620c3, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=NEJM：Sofosbuvir 及Velpatasvir治疗基因型1、2、4、5及 6的HCV感染患者的效果, objectType=article, longId=61524, objectId=6a3c6152469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a3c6152469, replyNumber=0, likeNumber=69, createdTime=2016-01-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a3c6152469, moduleTitle=NEJM：Sofosbuvir 及Velpatasvir治疗基因型1、2、4、5及 6的HCV感染患者的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a3c6152469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257619, encodeId=4fb8125e6196a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Medicine ：HCV可能不是骨质疏松症发生的主要因素, objectType=article, longId=61197, objectId=a3566119e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3566119e5d, replyNumber=0, likeNumber=54, createdTime=2015-12-29, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3566119e5d, moduleTitle=Medicine ：HCV可能不是骨质疏松症发生的主要因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3566119e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257618, encodeId=97dc125e61803, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=AIM：联合抗病毒剂治疗HCV-1型感染的肝纤维化患者，治愈率有限, objectType=article, longId=60886, objectId=0dba608868b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dba608868b, replyNumber=0, likeNumber=23, createdTime=2015-12-22, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dba608868b, moduleTitle=AIM：联合抗病毒剂治疗HCV-1型感染的肝纤维化患者，治愈率有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dba608868b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257617, encodeId=3081125e6172f, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Medicine：HCV感染者脑出血风险增加，尤其是年轻患者, objectType=article, longId=59275, objectId=ecfd592e50c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecfd592e50c, replyNumber=0, likeNumber=26, createdTime=2015-11-23, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecfd592e50c, moduleTitle=Medicine：HCV感染者脑出血风险增加，尤其是年轻患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecfd592e50c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257616, encodeId=65e8125e616ad, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案, objectType=article, longId=59145, objectId=256459145ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=256459145ee, replyNumber=0, likeNumber=65, createdTime=2015-11-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=256459145ee, moduleTitle=NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=256459145ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257615, encodeId=4860125e615f9, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率, objectType=article, longId=58934, objectId=42b75893460, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42b75893460, replyNumber=0, likeNumber=106, createdTime=2015-11-18, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42b75893460, moduleTitle=NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42b75893460)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257614, encodeId=3538125e614ac, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=警惕！医护人员HCV感染率较高, objectType=article, longId=58578, objectId=7e4c585e867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e4c585e867, replyNumber=0, likeNumber=70, createdTime=2015-11-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4c585e867, moduleTitle=警惕！医护人员HCV感染率较高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e4c585e867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257613, encodeId=dfdd125e61331, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=PLoS One：北京过去5年HBV、HCV、HIV、TP发生情况, objectType=article, longId=57925, objectId=9b605e9256c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b605e9256c, replyNumber=0, likeNumber=70, createdTime=2015-10-29, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b605e9256c, moduleTitle=PLoS One：北京过去5年HBV、HCV、HIV、TP发生情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b605e9256c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257612, encodeId=edf3125e61279, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Lancet：终末期慢性肾病患者的HCV感染有救了！, objectType=article, longId=57664, objectId=fd7a5e6646b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd7a5e6646b, replyNumber=0, likeNumber=72, createdTime=2015-10-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd7a5e6646b, moduleTitle=Lancet：终末期慢性肾病患者的HCV感染有救了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd7a5e6646b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257611, encodeId=f335125e61173, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Lancet：4-5期慢性肾病患者感染HCV治疗：grazoprevir和elbasvir效果良好, objectType=article, longId=57067, objectId=fde15e0670c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde15e0670c, replyNumber=0, likeNumber=68, createdTime=2015-10-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde15e0670c, moduleTitle=Lancet：4-5期慢性肾病患者感染HCV治疗：grazoprevir和elbasvir效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fde15e0670c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257610, encodeId=bee0125e6104a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Medicine： HCV感染增加深静脉血栓的风险, objectType=article, longId=56637, objectId=e1905663e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1905663e9e, replyNumber=0, likeNumber=56, createdTime=2015-09-28, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1905663e9e, moduleTitle=Medicine： HCV感染增加深静脉血栓的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1905663e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257609, encodeId=3288125e609e2, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, objectType=article, longId=53683, objectId=f61b53683e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f61b53683e0, replyNumber=0, likeNumber=52, createdTime=2015-07-24, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f61b53683e0, moduleTitle=NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f61b53683e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257608, encodeId=b932125e608e5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=AIM：Grazoprevir和Elbasvir的新组合方案为HCV感染者提供了新的治疗选择, objectType=article, longId=53210, objectId=e67d53210e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e67d53210e4, replyNumber=0, likeNumber=54, createdTime=2015-07-13, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e67d53210e4, moduleTitle=AIM：Grazoprevir和Elbasvir的新组合方案为HCV感染者提供了新的治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e67d53210e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257607, encodeId=7986125e6075e, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者, objectType=article, longId=53180, objectId=16e6531804a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e6531804a, replyNumber=0, likeNumber=61, createdTime=2015-07-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e6531804a, moduleTitle=Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16e6531804a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257606, encodeId=1dbb125e6063d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果, objectType=article, longId=49877, objectId=9697498e729, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9697498e729, replyNumber=0, likeNumber=85, createdTime=2015-04-27, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9697498e729, moduleTitle=AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9697498e729)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257605, encodeId=622f125e605b3, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Lancet：新联合用药手段治疗HCV-4感染效果理想, objectType=article, longId=48891, objectId=336848891d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336848891d5, replyNumber=0, likeNumber=55, createdTime=2015-04-03, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336848891d5, moduleTitle=Lancet：新联合用药手段治疗HCV-4感染效果理想, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=336848891d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257604, encodeId=e282125e6044f, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=JAMA：联合用药治疗HIV、HCV共感染, objectType=article, longId=48834, objectId=b1fa4883448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1fa4883448, replyNumber=0, likeNumber=93, createdTime=2015-04-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1fa4883448, moduleTitle=JAMA：联合用药治疗HIV、HCV共感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1fa4883448)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：他汀类药物可帮助HCV患者降低肝硬化和HCC风险

2016-03-08

爆笑小医 (审核中...)

前往app查看评论内容

#HCV#

Lancet infect dis：HIV合并HCV感染的负担（全球性meta分析）

2016-02-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：感染HCV对心血管疾病风险的影响

2016-01-28

ymljack (审核中...)

前往app查看评论内容

#HCV#

NEJM：Sofosbuvir 及Velpatasvir治疗基因型1、2、4、5及 6的HCV感染患者的效果

2016-01-04

docwu2019 (审核中...)

前往app查看评论内容

#HCV#

Medicine ：HCV可能不是骨质疏松症发生的主要因素

2015-12-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

AIM：联合抗病毒剂治疗HCV-1型感染的肝纤维化患者，治愈率有限

2015-12-22

ymljack (审核中...)

前往app查看评论内容

#HCV#

Medicine：HCV感染者脑出血风险增加，尤其是年轻患者

2015-11-23

ymljack (审核中...)

前往app查看评论内容

#HCV#

NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案

2015-11-21

ymljack (审核中...)

前往app查看评论内容

#HCV#

NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率

2015-11-18

ymljack (审核中...)

前往app查看评论内容

#HCV#

警惕！医护人员HCV感染率较高

2015-11-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

PLoS One：北京过去5年HBV、HCV、HIV、TP发生情况

2015-10-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

Lancet：终末期慢性肾病患者的HCV感染有救了！

2015-10-24

ymljack (审核中...)

前往app查看评论内容

#HCV#

Lancet：4-5期慢性肾病患者感染HCV治疗：grazoprevir和elbasvir效果良好

2015-10-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

Medicine： HCV感染增加深静脉血栓的风险

2015-09-28

ymljack (审核中...)

前往app查看评论内容

#HCV#

NEJM：Ledipasvir/Sofosbuvir治疗提高了HIV-1/HCV共感染患者的持续病毒学应答率

2015-07-24

ymljack (审核中...)

前往app查看评论内容

#HCV#

AIM：Grazoprevir和Elbasvir的新组合方案为HCV感染者提供了新的治疗选择

2015-07-13

ymljack (审核中...)

前往app查看评论内容

#HCV#

Lancet HIV：Grazoprevir加Elbasvir可有效治疗HIV和HCV共感染的患者

2015-07-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

AIM：Grazoprevir-Elbasvir联合对慢性丙肝（HCV）治疗抵抗患者有显著效果

2015-04-27

ymljack (审核中...)

前往app查看评论内容

#HCV#

Lancet：新联合用药手段治疗HCV-4感染效果理想

2015-04-03

ymljack (审核中...)

前往app查看评论内容

#HCV#

JAMA：联合用药治疗HIV、HCV共感染

2015-04-02

科室
- - 订阅+
  - 更多科室
工具
服务